Bridge to Life has received FDA De Novo clearance for its VitaSmart hypothermic oxygenated perfusion (HOPE) system for liver ...
Every transplant begins as a race against time. Once an organ leaves the body, its condition begins to decline. For decades, static cold storage, where an organ is placed on ice, has been the standard ...
The FDA clearance enables the commercial use of VitaSmart (TM) for hypothermic oxygenated perfusion of donor livers following static cold storage and prior to transplantation, providing a clear, ...
Please provide your email address to receive an email when new articles are posted on . Tissue perfusion pressure may be a new target for BP optimization in circulatory shock. TPP was significantly ...
Bridge to Life™ Ltd., a global innovator in organ preservation and perfusion technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo clearance for the ...
Bridge To Lifetm Secures FDA De Novo Clearance For Vitasmarttm Hypothermic Oxygenated Perfusion (HOPE) System, The First Device Cleared In The U.S. For Hypothermic Oxygenated Perfusion Of Donor Livers ...
Bridge to Life™ Ltd., a global innovator in organ preservation and perfusion technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo clearance for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results